Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Variation in the SLC23A1 gene does not influence cardiometabolic outcomes to the extent expected given its association with L-ascorbic acid.

Wade KH, Forouhi NG, Cook DG, Johnson P, McConnachie A, Morris RW, Rodriguez S, Ye Z, Ebrahim S, Padmanabhan S, Watt G, Bruckdorfer KR, Wareham NJ, Whincup PH, Chanock S, Sattar N, Lawlor DA, Davey Smith G, Timpson NJ.

Am J Clin Nutr. 2015 Jan;101(1):202-9. doi: 10.3945/ajcn.114.092981. Epub 2014 Nov 19.

2.

Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon.

Kundu D, Abraham D, Black CM, Denton CP, Bruckdorfer KR.

Vascul Pharmacol. 2014 Dec;63(3):178-81. doi: 10.1016/j.vph.2014.09.003. Epub 2014 Oct 15.

3.

Plasma vitamin C, but not vitamin E, is associated with reduced risk of heart failure in older men.

Wannamethee SG, Bruckdorfer KR, Shaper AG, Papacosta O, Lennon L, Whincup PH.

Circ Heart Fail. 2013 Jul;6(4):647-54. doi: 10.1161/CIRCHEARTFAILURE.112.000281. Epub 2013 May 31.

PMID:
23729199
4.

Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants.

Dooley A, Bruckdorfer KR, Abraham DJ.

Cardiol Res Pract. 2012;2012:521958. doi: 10.1155/2012/521958. Epub 2011 Oct 31.

5.

Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants.

Timpson NJ, Forouhi NG, Brion MJ, Harbord RM, Cook DG, Johnson P, McConnachie A, Morris RW, Rodriguez S, Luan J, Ebrahim S, Padmanabhan S, Watt G, Bruckdorfer KR, Wareham NJ, Whincup PH, Chanock S, Sattar N, Lawlor DA, Davey Smith G.

Am J Clin Nutr. 2010 Aug;92(2):375-82. doi: 10.3945/ajcn.2010.29438. Epub 2010 Jun 2. Erratum in: Am J Clin Nutr. 2013 Jul;98(1):253-4.

6.

Antioxidants and CVD.

Bruckdorfer KR.

Proc Nutr Soc. 2008 May;67(2):214-22. doi: 10.1017/S0029665108007052. Review.

PMID:
18412995
7.

Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis.

Dooley A, Low SY, Holmes A, Kidane AG, Abraham DJ, Black CM, Bruckdorfer KR.

Rheumatology (Oxford). 2008 Mar;47(3):272-80. doi: 10.1093/rheumatology/kem303. Epub 2008 Jan 30.

PMID:
18238792
8.

Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts.

Dooley A, Gao B, Shi-Wen X, Abraham DJ, Black CM, Jacobs M, Bruckdorfer KR.

Free Radic Biol Med. 2007 Jul 15;43(2):253-64. Epub 2007 Apr 29.

PMID:
17603934
9.

Differential functions of tissue factor in the trans-activation of cellular signalling pathways.

Ettelaie C, Li C, Collier ME, Pradier A, Frentzou GA, Wood CG, Chetter IC, McCollum PT, Bruckdorfer KR, James NJ.

Atherosclerosis. 2007 Sep;194(1):88-101. Epub 2006 Nov 29.

PMID:
17137581
10.

The influence of organic peroxides on platelet aggregation and sensitivity to nitric oxide.

Naseem KM, Bruckdorfer KR.

Platelets. 1999;10(2-3):146-52.

PMID:
16801085
11.

Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis.

Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH.

Am J Clin Nutr. 2006 Mar;83(3):567-74; quiz 726-7.

PMID:
16522902
12.

Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.

Dooley A, Gao B, Bradley N, Abraham DJ, Black CM, Jacobs M, Bruckdorfer KR.

Rheumatology (Oxford). 2006 Jun;45(6):676-84. Epub 2006 Jan 6.

PMID:
16399843
13.
14.

Observational versus randomised trial evidence.

Lawlor DA, Davey Smith G, Bruckdorfer KR, Kundu D, Ebrahim S.

Lancet. 2004 Aug 28-Sep 3;364(9436):755. No abstract available.

PMID:
15337394
15.

Nitric oxide signaling in platelets.

Low SY, Bruckdorfer KR.

Methods Mol Biol. 2004;273:313-34. No abstract available.

PMID:
15308809
16.

Roles for prostaglandins in the steroidogenic response of human granulosa cells to high-density lipoproteins.

Chandras C, Ragoobir J, Barrett GE, Bruckdorfer KR, Graham A, Abayasekara DR, Michael AE.

Mol Cell Endocrinol. 2004 Jul 30;222(1-2):1-8.

PMID:
15249120
17.

Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?

Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim S.

Lancet. 2004 May 22;363(9422):1724-7. No abstract available.

PMID:
15158637
18.

Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces.

Kidane AG, Salacinski H, Tiwari A, Bruckdorfer KR, Seifalian AM.

Biomacromolecules. 2004 May-Jun;5(3):798-813. Review.

PMID:
15132664
19.

Circulating levels of the chemokines JE and KC in female C3H apolipoprotein-E-deficient and C57BL apolipoprotein-E-deficient mice as potential markers of atherosclerosis development.

Parkin SL, Pritchett JP, Grimsditch DC, Bruckdorfer KR, Sahota PK, Lloyd A, Overend P, Benson GM.

Biochem Soc Trans. 2004 Feb;32(Pt 1):128-30.

PMID:
14748730
20.

The state of macrophage differentiation determines the TNF alpha response to nitrated lipoprotein uptake.

Smythe CD, Skinner VO, Bruckdorfer KR, Haskard DO, Landis RC.

Atherosclerosis. 2003 Oct;170(2):213-21.

PMID:
14612200
21.

Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice.

Murphy N, Bruckdorfer KR, Grimsditch DC, Overend P, Vidgeon-Hart M, Groot PH, Benson GM, Graham A.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1615-20. Epub 2003 Jul 3.

PMID:
12842836
22.

The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans.

Pannala AS, Mani AR, Spencer JP, Skinner V, Bruckdorfer KR, Moore KP, Rice-Evans CA.

Free Radic Biol Med. 2003 Mar 1;34(5):576-84.

PMID:
12614846
23.

Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase.

Beaumont NJ, Skinner VO, Tan TM, Ramesh BS, Byrne DJ, MacColl GS, Keen JN, Bouloux PM, Mikhailidis DP, Bruckdorfer KR, Vanderpump MP, Srai KS.

J Biol Chem. 2003 Mar 14;278(11):8877-80. Epub 2003 Jan 16.

24.

Enhanced relaxation of diabetic rabbit cavernosal smooth muscle in response to nitric oxide: potential relevance to erectile dysfunction.

Sullivan ME, Mumtaz FH, Dashwood MR, Thompson CS, Naseem KM, Bruckdorfer KR, Mikhailidis DP, Morgan RJ.

Int J Impot Res. 2002 Dec;14(6):523-32.

25.

Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.

Jones DT, Ganeshaguru K, Anderson RJ, Jackson TR, Bruckdorfer KR, Low SY, Palmqvist L, Prentice HG, Hoffbrand AV, Mehta AB, Wickremasinghe RG.

Blood. 2003 Apr 15;101(8):3174-80. Epub 2002 Dec 12.

26.

Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure.

Bennett-Richards KJ, Kattenhorn M, Donald AE, Oakley GR, Varghese Z, Bruckdorfer KR, Deanfield JE, Rees L.

Kidney Int. 2002 Oct;62(4):1372-8.

27.

The nitration of proteins in platelets: significance in platelet function.

Sabetkar M, Low SY, Naseem KM, Bruckdorfer KR.

Free Radic Biol Med. 2002 Sep 15;33(6):728-36. Review.

PMID:
12208361
28.

Inhibition of tissue factor activity reduces the density of cellular network formation in an in vitro model of angiogenesis.

James NJ, Ettelaie C, Bruckdorfer KR.

Biochem Soc Trans. 2002 Apr;30(2):217-21.

PMID:
12023854
29.
30.

Smoking has no effect on the amino acid composition of apolipoprotein B100 of LDL while directly influencing the antioxidant status.

Sekher Pannala A, Bruckdorfer KR, Rice-Evans CA.

Biochem Biophys Res Commun. 2002 Mar 22;292(1):175-83.

PMID:
11890689
31.

The role of protein nitration in the inhibition of platelet activation by peroxynitrite.

Low SY, Sabetkar M, Bruckdorfer KR, Naseem KM.

FEBS Lett. 2002 Jan 30;511(1-3):59-64.

32.

The nitration of proteins in platelets.

Bruckdorfer KR.

C R Acad Sci III. 2001 Jul;324(7):611-5. Review.

PMID:
11476002
33.
34.

Phosphatidylserine-dependent adhesion of T cells to endothelial cells.

Qu J, Adam J, Bloxham DM, Bruckdorfer KR, Miller NG, Parkinson NA, Lucy JA.

Biochim Biophys Acta. 2000 Jun 15;1501(2-3):99-115.

35.

The nitration of platelet cytosolic proteins during agonist-induced activation of platelets.

Naseem KM, Low SY, Sabetkar M, Bradley NJ, Khan J, Jacobs M, Bruckdorfer KR.

FEBS Lett. 2000 May 4;473(1):119-22.

36.

Platelets, oxidant stress and erectile dysfunction: an hypothesis.

Jeremy JY, Angelini GD, Khan M, Mikhailidis DP, Morgan RJ, Thompson CS, Bruckdorfer KR, Naseem KM.

Cardiovasc Res. 2000 Apr;46(1):50-4. Review. No abstract available.

PMID:
10727652
37.

Relaxation of rabbit lower urinary tract smooth muscle by nitric oxide and carbon monoxide: modulation by hydrogen peroxide.

Naseem KM, Mumtaz FH, Thompson CS, Sullivan ME, Khan MA, Morgan RJ, Mikhailidis DP, Bruckdorfer KR.

Eur J Pharmacol. 2000 Jan 17;387(3):329-35.

PMID:
10650179
38.

The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor.

Ettelaie C, Adam JM, James NJ, Oke AO, Harrison JA, Bunce TD, Bruckdorfer KR.

FEBS Lett. 1999 Dec 17;463(3):341-4.

39.

Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation.

Mabile L, Bruckdorfer KR, Rice-Evans C.

Atherosclerosis. 1999 Nov 1;147(1):177-85.

PMID:
10525139
40.
41.

Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation.

Ettelaie C, Wilbourn BR, Adam JM, James NJ, Bruckdorfer KR.

Arterioscler Thromb Vasc Biol. 1999 Jul;19(7):1784-90.

PMID:
10397699
42.

Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.

Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K, Bruckdorfer KR, Black CM.

Rheumatology (Oxford). 1999 Apr;38(4):309-15.

PMID:
10378706
43.

Lipid oxidation products and vascular function.

Bruckdorfer KR.

Free Radic Res. 1998 Jun;28(6):573-81. Review.

PMID:
9736309
44.

Modification of tissue factor by peroxynitrite influences its procoagulant activity.

Adam JM, Ettelaie C, Naseem KM, James NJ, Bradley NJ, Bruckdorfer KR.

FEBS Lett. 1998 Jun 16;429(3):347-50.

45.

Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factor.

Ettelaie C, James NJ, Adam JM, Nicola KP, Wilbourn BR, Bruckdorfer KR.

Biochem J. 1998 Jul 15;333 ( Pt 2):433-8.

46.

Trans mono-unsaturated fatty acids and tissue factor activity in a monocytic cell line.

Bunce T, Jacobs M, Bruckdorfer KR.

Biochem Soc Trans. 1998 May;26(2):S157. No abstract available.

PMID:
9649832
47.

Trans monounsaturated fatty acid and the oxidation of low density lipoproteins.

Bunce T, Jacobs M, Bruckdorfer KR.

Biochem Soc Trans. 1998 May;26(2):S156. No abstract available.

PMID:
9649831
48.

Modulatory role of lipoprotein oxidation on platelet-vessel wall interactions.

Bruckdorfer KR.

Prostaglandins Leukot Essent Fatty Acids. 1997 Oct;57(4-5):493-7. Review.

PMID:
9430402
49.

Nitration of platelet cytosolic proteins by peroxynitrite.

Naseem KM, Khan J, Jacobs M, Bruckdorfer KR.

Biochem Soc Trans. 1997 Aug;25(3):397S. No abstract available.

PMID:
9388627
50.

Inhibition of platelet activation by carbon monoxide: comparison with nitric oxide.

Naseem KM, Bruckdorfer KR.

Biochem Soc Trans. 1997 Aug;25(3):396S. No abstract available.

PMID:
9388626

Supplemental Content

Loading ...
Support Center